Cantor Fitzgerald Maintains Overweight on MyoKardia, Lowers Price Target to $95

Cantor Fitzgerald maintains MyoKardia (NASDAQ:MYOK) with a Overweight and lowers the price target from $100 to $95.

Benzinga · 11/13/2019 12:17

Cantor Fitzgerald maintains MyoKardia (NASDAQ:MYOK) with a Overweight and lowers the price target from $100 to $95.